Regeneron's Key Franchises

Jim interviews Regeneron CEO Leonard Schleifer on Dupixent, retinal therapy ILEA, and potent cholesterol drug potential.

Play episode from 27:38

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!